GenoMed will offer nationwide influenza trial to help battle flu season
GenoMed will offer nationwide influenza trial to help battle flu season
ST. LOUIS, MO., October 13, 2004 -- U.S. genomics research company GenoMed announced that it will offer its patent-pending broad spectrum viral antidote to the nation during the flu season this fall and winter as a way to help people battle the possible outbreak in the months to come.
As reported in the news recently, nearly half of this year's flu vaccine doses destined for the U.S. will not be delivered in time for this year's flu season. GenoMed's novel protocol uses a class of blood pressure medications to treat viral diseases, such as the flu. Unlike the flu vaccination, there is no shortage of these protocol medications worldwide. GenoMed says it has had 100 percent success in treating a small number of normal, immunocompetent patients suffering from West Nile virus encephalitis during the past two summers, including the elderly.
GenoMed's first case series of eight patients was published in July, 2004 in Current Topics in Medicinal Chemistry, a peer-reviewed medical journal. Both the White House Office of Science Technology & Policy and the Department of Homeland Security have expressed interest in GenoMed's potential broad-spectrum viral antidote. GenoMed will be meeting during October with the National Institute of Allergy and Infectious Diseases (NIAID) to discuss further testing of its approach against viral diseases, including influenza.
CONTACT: dwmoskowitz@genomedics.com
Source: GenoMed
Pharma Industry News Archive
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec





